Interestingly, a pilot study found that in BRAF + MEK inhibitor-resistant melanoma, chemotherapy can be a successful treatment modality if it induces pyroptosis, an immunogenic form of cell death [39]. The gene discussed is MAP2K7; the disease is melanoma.